ECSP18000097A - TYROSINE-KINASE INHIBITORS - Google Patents
TYROSINE-KINASE INHIBITORSInfo
- Publication number
- ECSP18000097A ECSP18000097A ECIEPI201897A ECPI201800097A ECSP18000097A EC SP18000097 A ECSP18000097 A EC SP18000097A EC IEPI201897 A ECIEPI201897 A EC IEPI201897A EC PI201800097 A ECPI201800097 A EC PI201800097A EC SP18000097 A ECSP18000097 A EC SP18000097A
- Authority
- EC
- Ecuador
- Prior art keywords
- tyrosine
- compounds
- kinase inhibitors
- inhibitors
- btk
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente divulgación proporciona compuestos que son inhibidores de tirosina-cinasas, en particular inhibidores de la tirosina-cinasa de Bruton (BTK), y, por lo tanto, son útiles para el tratamiento de enfermedades que se pueden tratar mediante la inhibición de BTK tales como el cáncer, enfermedades autoinmunitarias, inflamatorias y tromboembólicas. También se proporcionan composiciones farmacéuticas que contienen tales compuestos y procesos para preparar tales compuestos.The present disclosure provides compounds that are inhibitors of tyrosine kinases, in particular inhibitors of Bruton's tyrosine kinase (BTK), and are therefore useful for the treatment of diseases that can be treated by inhibiting BTK such as such as cancer, autoimmune, inflammatory and thromboembolic diseases. Pharmaceutical compositions containing such compounds and processes for preparing such compounds are also provided.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562170547P | 2015-06-03 | 2015-06-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP18000097A true ECSP18000097A (en) | 2018-10-31 |
Family
ID=59724528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECIEPI201897A ECSP18000097A (en) | 2015-06-03 | 2018-01-02 | TYROSINE-KINASE INHIBITORS |
Country Status (3)
| Country | Link |
|---|---|
| AR (1) | AR104865A1 (en) |
| EC (1) | ECSP18000097A (en) |
| MA (1) | MA45367B1 (en) |
-
2016
- 2016-06-02 AR ARP160101618A patent/AR104865A1/en unknown
- 2016-06-02 MA MA45367A patent/MA45367B1/en unknown
-
2018
- 2018-01-02 EC ECIEPI201897A patent/ECSP18000097A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR104865A1 (en) | 2017-08-23 |
| MA45367B1 (en) | 2021-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20180521A1 (en) | TYROSINE-KINASE INHIBITORS | |
| PH12017501921A1 (en) | Novel compounds | |
| PH12018501268A1 (en) | Compounds useful as kinase inhibitors | |
| NZ729603A (en) | Heteroaryl compounds as btk inhibitors and uses thereof | |
| MX2017006366A (en) | 6-amino-7-bicyclo-7-deaza-purine derivatives as protein kinase inhibitors. | |
| CL2015001985A1 (en) | Thiazolcarboxamides and pyridinecarboxamide compounds, pim kinase inhibitors. | |
| MX2018003351A (en) | Pyrazolopyrimidine derivatives as btk inhibitors for the treatment of cancer. | |
| CO2017007121A2 (en) | Fused bicyclic compounds for the treatment of diseases | |
| PH12016502291A1 (en) | Indolizine derivatives as phosphoinositide 3-kinases inhibitors | |
| CR20170249A (en) | FORMS IN SOLID STATE OF FUSIONED HETEROAROMATIC PIRROLIDINONES | |
| BR112017007063A2 (en) | compositions and methods for treating insomnia | |
| BR112017008045A2 (en) | compounds as nik inhibitors | |
| BR112017007715A2 (en) | thienopyrimidine derivatives as nik inhibitors | |
| WO2016160621A3 (en) | Nk-92 cells in combination therapy with cancer drugs | |
| MX2017013137A (en) | Chromene derivatives as phoshoinositide 3-kinases inhibitors. | |
| MX2016009655A (en) | Novel methods for treating cancer. | |
| CO2017000586A2 (en) | Tablet formulation of 2-fluoro-n-methyl-4- [7- (quinolin-6-ylmethyl) imidazo [1,2-b] [1,2,4] triazin-2-yl] benzamide | |
| BR112018008931A2 (en) | "compounds for treating hypoproliferative disorders" | |
| PH12017501122A1 (en) | Substituted pyridyl-cycloalkyl-carboxylic acids, compositions containing them and medical uses thereof | |
| MX2017009608A (en) | Anti-cancer compounds. | |
| MX2017014752A (en) | Novel amidoheteroaryl aroyl hydrazide ethynes. | |
| MX2016004094A (en) | Pharmaceutical composition comprising capecitabine and cyclophosphamide. | |
| ECSP18000097A (en) | TYROSINE-KINASE INHIBITORS |